Hiroki Hoshino
Papers
2
Total Citations
2
H-Index
1
About
Hiroki Hoshino is a leading urologic surgeon and researcher whose work focuses on advancing surgical techniques for bladder cancer, particularly through robot-assisted radical cystectomy (RARC) and intracorporeal urinary diversion. His major contributions center on improving perioperative outcomes and expanding treatment options for patients with muscle-invasive bladder cancer (MIBC). Notably, Hoshino has explored the significance of split-dose cisplatin-based neoadjuvant chemotherapy (NAC) prior to robotic-assisted cystectomy, demonstrating that this modified regimen can preserve renal function while maintaining oncologic efficacy—a critical advancement given cisplatin’s nephrotoxicity. His narrative review on robot-assisted radical cystectomy with intracorporeal ileal neobladder reconstruction highlights the technical feasibility and potential benefits of this minimally invasive approach, including reduced complications and faster recovery. While his most-cited works are recent (2024–2025), with citations still accumulating, they address pressing clinical challenges: balancing aggressive cancer treatment with quality of life. Hoshino’s research is particularly valuable for surgeons and oncologists seeking evidence-based protocols for complex bladder cancer cases, positioning him as an emerging authority in robotic urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2